John W. Meyer, President & COO, and Charles S. Arnold, Chairman & CEO of Stemtech Corporation STEK were recently interviewed by Benzinga.
Stemtech is a pioneer in the “stemceuticals” space. The company creates and markets nutritional supplements it says help spur the body’s natural production of adult stem cells. Stem cells play an integral role in the body’s ability to heal itself and repair damaged tissues.
Stemtech has a successful direct marketing approach that it believes can help it continue to grow as public awareness of stem cells grows as well.
Watch the full interview here:
Featured photo by Pawel Czerwinski on Unsplash.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.